Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
JACC. Advances|June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVRRoxana Mehran, Alessandro Spirito, James Jin, et al.
JACC. Cardiovascular Interventions|September 21, 2015
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation)Marco Barbanti, Simona Gulino, Piera Capranzano, et al.
European Heart Journal|March 7, 2023
Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statementGill Louise Buchanan, Valeria Paradies, Nicole Karam, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 2, 2017
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP scoreLuis Ortega-Paz, Davide Capodanno, Tommaso Gori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 13, 2016
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registryLuis Ortega-Paz, Davide Capodanno, Giuseppe Giacchi, et al.
Giornale Italiano Di Cardiologia (2006)|October 13, 2016
[SICI-GISE Position paper: Use of Absorb BVS in clinical practice]Giuseppe Tarantini, Francesco Saia, Piera Capranzano, et al.
Journal of the American Heart Association|February 22, 2022
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA RegistriesFrancesco Moroni, Alessandro Beneduce, Gennaro Giustino, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
European Heart Journal|May 20, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
JACC. Cardiovascular Interventions|April 8, 2017
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main LesionsRichard J Jabbour, Akihito Tanaka, Piera Capranzano, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
JACC. Advances|June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVRRoxana Mehran, Alessandro Spirito, James Jin, et al.
JACC. Cardiovascular Interventions|September 21, 2015
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation)Marco Barbanti, Simona Gulino, Piera Capranzano, et al.
European Heart Journal|March 7, 2023
Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statementGill Louise Buchanan, Valeria Paradies, Nicole Karam, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 2, 2017
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP scoreLuis Ortega-Paz, Davide Capodanno, Tommaso Gori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 13, 2016
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registryLuis Ortega-Paz, Davide Capodanno, Giuseppe Giacchi, et al.
Giornale Italiano Di Cardiologia (2006)|October 13, 2016
[SICI-GISE Position paper: Use of Absorb BVS in clinical practice]Giuseppe Tarantini, Francesco Saia, Piera Capranzano, et al.
Journal of the American Heart Association|February 22, 2022
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA RegistriesFrancesco Moroni, Alessandro Beneduce, Gennaro Giustino, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
European Heart Journal|May 20, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
JACC. Cardiovascular Interventions|April 8, 2017
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main LesionsRichard J Jabbour, Akihito Tanaka, Piera Capranzano, et al.
Pageof 23